rs5738

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001039.4(SCNN1G):​c.589G>A​(p.Glu197Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00777 in 1,614,198 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E197Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0054 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0080 ( 65 hom. )

Consequence

SCNN1G
NM_001039.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:10

Conservation

PhyloP100: 0.886

Publications

24 publications found
Variant links:
Genes affected
SCNN1G (HGNC:10602): (sodium channel epithelial 1 subunit gamma) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the gamma subunit, and mutations in this gene have been associated with Liddle syndrome. [provided by RefSeq, Apr 2009]
SCNN1G Gene-Disease associations (from GenCC):
  • Liddle syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • bronchiectasis with or without elevated sweat chloride 3
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • Liddle syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • pseudohypoaldosteronism, type IB1, autosomal recessive
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.035057962).
BP6
Variant 16-23189642-G-A is Benign according to our data. Variant chr16-23189642-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 8829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 7 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCNN1GNM_001039.4 linkc.589G>A p.Glu197Lys missense_variant Exon 3 of 13 ENST00000300061.3 NP_001030.2 P51170A5X2V1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCNN1GENST00000300061.3 linkc.589G>A p.Glu197Lys missense_variant Exon 3 of 13 1 NM_001039.4 ENSP00000300061.2 P51170

Frequencies

GnomAD3 genomes
AF:
0.00537
AC:
818
AN:
152200
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00176
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00661
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00869
Gnomad OTH
AF:
0.00955
GnomAD2 exomes
AF:
0.00503
AC:
1264
AN:
251464
AF XY:
0.00541
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00520
Gnomad ASJ exome
AF:
0.00506
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00125
Gnomad NFE exome
AF:
0.00827
Gnomad OTH exome
AF:
0.00684
GnomAD4 exome
AF:
0.00802
AC:
11726
AN:
1461880
Hom.:
65
Cov.:
34
AF XY:
0.00785
AC XY:
5712
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.000866
AC:
29
AN:
33480
American (AMR)
AF:
0.00559
AC:
250
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
113
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86254
European-Finnish (FIN)
AF:
0.00133
AC:
71
AN:
53420
Middle Eastern (MID)
AF:
0.00295
AC:
17
AN:
5768
European-Non Finnish (NFE)
AF:
0.00967
AC:
10757
AN:
1112004
Other (OTH)
AF:
0.00785
AC:
474
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
647
1293
1940
2586
3233
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00537
AC:
818
AN:
152318
Hom.:
7
Cov.:
32
AF XY:
0.00470
AC XY:
350
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00176
AC:
73
AN:
41576
American (AMR)
AF:
0.00660
AC:
101
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00869
AC:
591
AN:
68028
Other (OTH)
AF:
0.00945
AC:
20
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
45
91
136
182
227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00803
Hom.:
31
Bravo
AF:
0.00596
TwinsUK
AF:
0.00755
AC:
28
ALSPAC
AF:
0.00960
AC:
37
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.00860
AC:
74
ExAC
AF:
0.00473
AC:
574
EpiCase
AF:
0.00916
EpiControl
AF:
0.0104

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
May 02, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 15, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25900089, 27264265, 28497567, 19462466, 18507830, 22933219) -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCNN1G: BP4, BS1 -

Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pseudohypoaldosteronism, type IB1, autosomal recessive Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bronchiectasis with or without elevated sweat chloride 3 Pathogenic:1
May 28, 2008
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bronchiectasis with or without elevated sweat chloride 3;C4748251:Liddle syndrome 2;C5774176:Pseudohypoaldosteronism, type IB1, autosomal recessive Benign:1
Apr 07, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Liddle syndrome 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.86
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.60
T
MetaRNN
Benign
0.035
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.57
N
PhyloP100
0.89
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.82
N
REVEL
Uncertain
0.41
Sift
Benign
0.36
T
Sift4G
Benign
0.60
T
Polyphen
0.0040
B
Vest4
0.14
MVP
0.51
MPC
0.24
ClinPred
0.0056
T
GERP RS
2.8
Varity_R
0.093
gMVP
0.52
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5738; hg19: chr16-23200963; COSMIC: COSV100264512; API